Medication compliance in outpatients with schizophrenia in one veterans hospital in Taiwan

Journal of Food and Drug Analysis

Volumn 17, Issue 6, 2009, Pages 401-407

  Huang, Weng Foung ^a   Cheng, Jur Shan ^b   Lai, I Ching ^c   Hsieh, Chi Feng ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c YULI VETERANS HOSPITAL   (Taiwan)

Author keywords

Antipsychotics; Medication compliance; Schizophrenia

Indexed keywords

AMISULPRIDE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SULPIRIDE;

ADULT; AGE; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; DEMOGRAPHY; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COMPLIANCE; PUBLIC HOSPITAL; SCHIZOPHRENIA; SELF REPORT; SOCIAL SUPPORT; STATISTICAL ANALYSIS; TAIWAN;

EID: 77949619363     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Llorca, P. M. 2008. Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Res. 161: 235-247.
2. Valenstein, M., Ganoczy, D., McCarthy, J. F., Myra Kim, H., Lee, T. A. and Blow, F. C. 2006. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J. Clin. Psychiatry 67: 1542-1550.
3. Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P. and Jeste, D. V. 2004. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am. J. Psychiatry 161: 692-699.
4. Dolder, C. R., Lacro, J. P. and Jeste, D. V. 2003. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosom. Med. 65: 156-162.
5. Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G. and Jeste, D. V. 2002. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 63: 892-909.
6. Leucht, S., Barnes, T. R., Kissling, W., Engel, R. R., Correll, C. and Kane, J. M. 2003. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am. J. Psychiatry 160: 1209-1222.
7. Law, M. R., Soumerai, S. B., Ross-Degnan, D. and Adams, A. S. 2008. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J. Clin. Psychiatry 69: 47-53.
8. Weiden, P. J., Kozma, C., Grogg, A. and Locklear. J. 2004. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr. Serv. 55: 886-891.
9. Ascher-Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S. and Swanson, J.W. 2006. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J. Clin. Psychiatry 67: 453-460.
10. Herings, R. M. and Erkens, J.A. 2003. Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidemiol. Drug. Saf. 12: 423-424.
11. De Hert, M., McKenzie, K. and Peuskens, J. 2001. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr. Res. 47: 127-134.
12. Thieda, P., Beard, S., Richter, A. and Kane, J. 2003. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr. Serv. 54: 508-516.
13. Dolder, C. R., Lacro, J. P., Leckband, S. and Jeste, D. V. 2003. Interventions to improve antipsychotic medication adherence: review of recent literature. J. Clin. Psychopharmacol. 23: 389-399.
14. Fleischhacker, W. W., Oehl, M. A. and Hummer, M. 2003. Factors influencing compliance in schizophrenia patients. J. Clin. Psychiatry 64 Suppl 16: 10-13.
15. Mutsatsa, S. H., Joyce, E. M., Hutton, S. B., Webb, E., Gibbins, H., Paul, S. and Barnes, T. R. 2003. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta. Psychiatr. Scand. 108: 439-446.
16. Prouteau, A., Verdoux, H., Briand, C., Lesage, A., Lalonde, P., Nicole, L., Reinharz, D. and Stip, E. 2005. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr. Res. 77: 343-353.
17. Robinson, D. G., Woerner, M. G., Alvir, J. M., Bilder, R. M., Hinrichsen, G. A. and Lieberman, J. A. 2002. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr. Res. 57: 209-219.
18. Margolese, H. C., Malchy, L., Negrete, J. C., Tempier, R. and Gill, K. 2004. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr. Res. 67: 157-166.
19. Liu-Seifert, H., Adams, D. H. and Kinon, B. J. 2005. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Med. 3: 21.
20. Löffler, W., Kilian, R., Toumi, M. and Angermeyer, M. C. 2003. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 36: 105-112.
21. Rittmannsberger, H., Pachinger, T., Keppelmüller, P. and Wancata, J. 2004. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatr. Serv. 55: 174-179.
22. Cooper, D., Moisan, J. and Grégoire, J. P. 2007. Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia. J. Clin. Psychiatry 68: 818-825.
23. Gianfrancesco, F. D., Rajagopalan, K., Sajatovic, M. and Wang, R. H. 2006. Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics. Psychiatry Res. 144: 177-189.
24. Gibson, P. J., Damier, R., Jackson, E. A., Wilder, T. and Ramsey, J. L. 2004. The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a Medicaid population. Value Health 7: 22-35.
25. Swanson, J. W., Swartz, M. S. and Elbogen, E. B. 2004. Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Schizophr. Bull. 30: 3-20.
26. Dolder, C. R., Lacro, J. P., Dunn, L. B. and Jeste, D. V. 2002. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am. J. Psychiatry 159: 103-108.
27. Haro, J. M., Edgell, E. T., Novick, D., Alonso, J., Kennedy, L., Jones, P. B., Ratcliffe, M., Breier, A. and SOHO advisory board. 2005. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta. Psychiatr. Scand. 111: 220-231.
28. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J., Hsiao, J. K., and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353: 1209-1223.
29. Valenstein, M., Blow, F. C., Copeland, L. A., McCarthy, J. F., Zeber, J. E., Gillon, L., Bingham, C. R. and Stavenger, T. 2004. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr. Bull. 30: 255-264.
30. Menzin, J., Boulanger, L., Friedman, M., Mackell, J. and Lloyd, J. R. 2003. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatr. Serv. 54: 719-723.
31. Stroup, T. S., McEvoy, J. P., Swartz, M. S., Byerly, M. J., Glick, I. D., Canive, J. M., McGee, M. F., Simpson, G. M., Stevens, M. C. and Lieberman, J. A. 2003. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr. Bull. 29: 15-31.
32. Yen, C. F., Chen, C. S., Ko, C. H., Yeh, M. L., Yang, S. J., Yen, J. Y., Huang, C. F. and Wu, C. C. 2005. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatry Clin. Neurosci. 59: 403-409.
33. Stahl, S. M. 2008. Stahl's essential psychopharmacology: neuroscientific basis and practical applications. 3rd ed. pp. 327-451, Grady, M. M. ed Cambridge University Press. New York, U. S. A.
34. Marwaha, S., Johnson, S., Bebbington, P., Stafford, M., Angermeyer, M. C., Brugha, T., Azorin, J. M., Kilian, R., Hansen, K. and Toumi, M. 2007. Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br. J. Psychiatry 191: 30-37.
35. Rosenheck, R., Leslie, D., Keefe, R., McEvoy, J., Swartz, M., Perkins, D., Stroup, S., Hsiao, J. K., Lieberman, J. and CATIE Study Investigators Group. 2006. Barriers to employment for people with schizophrenia. Am. J. Psychiatry 163: 411-417.
36. Hudson, T. J., Owen, R. R., Thrush, C. R., Han, X., Pyne, J. M., Thapa, P. and Sullivan, G. 2004. A pilot study of barriers to medication adherence in schizophrenia. J. Clin. Psychiatry 65: 211-216.
37. Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., Lieberman, J. A., Comparison of Atypicals in First Episode study group 2008. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J. Clin. Psychiatry 69: 106-113.
38. Diaz, E., Levine, H. B., Sullivan, M. C., Sernyak, M. J., Hawkins, K. A., Cramer, J. A. and Woods, S. W. 2001. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J. Psychiatry Neurosci. 26: 325-329.